{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:51:50Z","timestamp":1777571510467,"version":"3.51.4"},"reference-count":68,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T00:00:00Z","timestamp":1447718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:p>Nausea and vomiting are a frequent accompaniment of migraine and anti\u2010nausea medications are frequently used in its management. The majority of anti\u2010nausea medications that are used in migraine are dopamine receptor blocking agents and therefore have the potential to cause drug\u2010induced movement disorders. This article explores the risk of such drug\u2010induced movement disorders in migraineurs who were treated with these medications.<\/jats:p>","DOI":"10.1111\/head.12712","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T01:02:40Z","timestamp":1447722160000},"page":"153-161","source":"Crossref","is-referenced-by-count":31,"title":["Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine"],"prefix":"10.1111","volume":"56","author":[{"given":"Subhashie","family":"Wijemanne","sequence":"first","affiliation":[{"name":"Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[{"name":"Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randolph W.","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Neurology Baylor College of Medicine Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,11,17]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.02070.x"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00781.x"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(05)81508-2"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(05)80201-X"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(94)70135-0"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2003.195"},{"key":"e_1_2_4_8_1","article-title":"An update on tardive dyskinesia: From phenomenology to treatment","volume":"3","author":"Waln O","year":"2013","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31829d86b6"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007312258"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000455698.16732.0a"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7352.1506"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-8343(92)90082-L"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790090075012"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.8.993"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10227"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870070110"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199106000-00013"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26209"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1989.00390110070015"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000320"},{"key":"e_1_2_4_22_1","article-title":"Neuroleptic malignant syndrome: Complications, outcomes, and mortality","author":"Modi S","year":"2015","journal-title":"Neurocrit Care."},{"key":"e_1_2_4_23_1","article-title":"Drug Induced Movement Disorders, Chapter 33","author":"Jankovic J","year":"2015","journal-title":"Parkinson's Disease and Movement Disorders"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/18.4.701"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1331\/1544345042467191"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199506000-00001"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6500.930"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000842"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25909"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25107"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2013.02.011"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1994.hed3407439.x"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38281.595718.7C"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0442"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410120051007"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2004.014712"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/1742-6723.12062"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2007.057570"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199807000-00045"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.1997.tb11474.x"},{"key":"e_1_2_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00840.x"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2006.00760.x"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.055"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04189.x"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370080133023"},{"key":"e_1_2_4_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.12.1304"},{"key":"e_1_2_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2010.11.023"},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2008.01.015"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(99)80048-1"},{"key":"e_1_2_4_50_1","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.113032"},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(00)00297-3"},{"key":"e_1_2_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2007.09.027"},{"key":"e_1_2_4_53_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P194"},{"key":"e_1_2_4_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12259"},{"key":"e_1_2_4_55_1","unstructured":"U.S. Food and Drug Administration. Reglan (metoclopramide) Tablets ODT (Orally Disintegrating Tablets) and Injection. 2010.http:\/\/wwwfdagov\/Safety\/MedWatch\/SafetyInformation\/ucm170934htm."},{"key":"e_1_2_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2008.08.003"},{"key":"e_1_2_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2003.11.011"},{"key":"e_1_2_4_58_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.2.358"},{"key":"e_1_2_4_59_1","doi-asserted-by":"publisher","DOI":"10.1586\/ern.11.149"},{"key":"e_1_2_4_60_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2015.1029573"},{"key":"e_1_2_4_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.2.170"},{"key":"e_1_2_4_62_1","doi-asserted-by":"publisher","DOI":"10.1586\/ern.10.58"},{"key":"e_1_2_4_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198808001-00008"},{"key":"e_1_2_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2006.05.009"},{"key":"e_1_2_4_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-010-9350-0"},{"key":"e_1_2_4_66_1","first-page":"203","article-title":"Ondansetron\u2010induced headache. Our experience in gynecological cancer","volume":"16","author":"Veneziano M","year":"1995","journal-title":"Eur J Gynaecol Oncol."},{"key":"e_1_2_4_67_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1993.1302124.x"},{"key":"e_1_2_4_68_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1984.0402085.x"},{"key":"e_1_2_4_69_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100118943"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhead.12712","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.12712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:48:22Z","timestamp":1762073302000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.12712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,17]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1111\/head.12712"],"URL":"https:\/\/doi.org\/10.1111\/head.12712","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,17]]}}}